Modulation of inflammatory leukocytes by an extracorporeal granulotrap column, G-1: Suppression of IL-1.BETA. production by peripheral blood mononuclear cells of patients with rheumatoid arthritis.:Suppression of IL-1β production by peripheral blood mo

概要

論文の詳細を見る
To investigate the mechanism of improvements in the symptoms of rheumatoid arthritis (RA) induced by an extracorporeal granulotrap column (G-1), an ex vivo study was undertaken on peripheral blood from RA patients while being treated with the G-1. Our focus was on the modulations of granulocytes and monocytes, but also on T cell function as well during or after completion of G-1 therapy. The G-1 column selectively trapped granulocytes and monocytes from peripheral blood with a trapping efficiency of about 40%. This resulted in a decrease in inflammatory leukocytes in the systemic blood during apheresis (p<0.05, n=14) . The production of TNF-α, IL-6 and IL-8 was also significantly decreased in blood stimulated by LPS at post column by compared with pre perfusion (p<0.02, n=9) . IFN-γproduction by T cells stimulated with anti CD3 MoAb showed a modest but significant decrease during apheresis (p<0.05, n=8) . Additionally, IL-1β production capacity of mononuclear cells stimulated with LPS was strikingly suppressed in studies of 6 patients (p<0.05) after the initiation of G-1; the effect was sustained for up to 2 weeks after completion of G-1 therapy. The results suggest that the G-1 column, in addition to trapping fraction of granulocytes and monocytes, also produces extracorporeal immunomodulation.
日本炎症・再生医学会の論文